534 related articles for article (PubMed ID: 22521832)
21. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
Buda A; Forss-Petter S; Hua R; Jaspers Y; Lassnig M; Waidhofer-Söllner P; Kemp S; Kim P; Weinhofer I; Berger J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759733
[TBL] [Abstract][Full Text] [Related]
22. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
23. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.
Ofman R; Dijkstra IM; van Roermund CW; Burger N; Turkenburg M; van Cruchten A; van Engen CE; Wanders RJ; Kemp S
EMBO Mol Med; 2010 Mar; 2(3):90-7. PubMed ID: 20166112
[TBL] [Abstract][Full Text] [Related]
24. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.
Strachan LR; Stevenson TJ; Freshner B; Keefe MD; Miranda Bowles D; Bonkowsky JL
Hum Mol Genet; 2017 Sep; 26(18):3600-3614. PubMed ID: 28911205
[TBL] [Abstract][Full Text] [Related]
25. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
26. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
[TBL] [Abstract][Full Text] [Related]
27. Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy.
Heinzer AK; Kemp S; Lu JF; Watkins PA; Smith KD
J Biol Chem; 2002 Aug; 277(32):28765-73. PubMed ID: 12048192
[TBL] [Abstract][Full Text] [Related]
28. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
29. Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters.
Leclercq S; Skrzypski J; Courvoisier A; Gondcaille C; Bonnetain F; André A; Chardigny JM; Bellenger S; Bellenger J; Narce M; Savary S
Biochimie; 2008 Oct; 90(10):1602-7. PubMed ID: 18585430
[TBL] [Abstract][Full Text] [Related]
30. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
31. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
[TBL] [Abstract][Full Text] [Related]
32. Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S; Wanders R
Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
[TBL] [Abstract][Full Text] [Related]
33. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
[TBL] [Abstract][Full Text] [Related]
34. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
35. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
Jia Z; Pei Z; Li Y; Wei L; Smith KD; Watkins PA
Mol Genet Metab; 2004; 83(1-2):117-27. PubMed ID: 15464426
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
[TBL] [Abstract][Full Text] [Related]
38. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet.
Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N
Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377
[TBL] [Abstract][Full Text] [Related]
39. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.
Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ
Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258
[TBL] [Abstract][Full Text] [Related]
40. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
Engelen M; Schackmann MJ; Ofman R; Sanders RJ; Dijkstra IM; Houten SM; Fourcade S; Pujol A; Poll-The BT; Wanders RJ; Kemp S
J Inherit Metab Dis; 2012 Nov; 35(6):1137-45. PubMed ID: 22447153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
